Joshua Fitch is the senior editor for Contemporary Pediatrics. He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown ...

Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application.

Among a study population of adults and adolescents aged 12 years and older with moderate-to-severe atopic dermatitis (AD) and skin of color, dupilumab (Dupixent; Regeneron Pharmaceuticals and Sanofi) ...

Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic ...

Colleen Sloan, PA-C, RDN, registered dietitian in pediatrics, host of The Exam Room Nutrition podcast, and nutrition columnist for Contemporary Pediatrics, discussed the connection between dietary ...

Editor's note: This is the third article in a series highlighting changes to COVID-19-vaccine-related changes from federal agencies. Click here for the first article highlighting the FDA's stricter ...

On May 28, 2025, the FDA approved Eton Pharmaceuticals' new drug application (NDA) for hydrocortisone oral solution (Khindivi) as a replacement therapy for pediatric patients aged 5 years or older ...

Victor Carrion, MD, director of the Stanford Early Life Stress Research Program and professor of child and adolescent psychiatry at Stanford University, emphasized that recognizing what children are ...

Since it was approved on July 17, 2023, nirsevimab (Beyfortus; Sanofi and AstraZeneca), has been a welcome tool for pediatric providers to fight against respiratory syncytial virus (RSV) disease in ...

The Case A previously healthy 11-year-old girl presented for an urgent mental health consultation with her pediatrician due to parental concerns about weight loss, food restriction, and mood ...

Distinguishable symptom patterns for long COVID (LC) were observed across infants and toddlers as well as preschool-aged children, according to new research published in JAMA Pediatrics that aimed to ...

In a video interview with Contemporary Pediatrics, Jennifer Soung, MD, further explained the benefits of roflumilast foam 0.3% can provide to those with scalp and body psoriasis and how this approval ...